VANGUARD GROUP INC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,291,966
-20.2%
3,187,420
+0.2%
0.00%0.0%
Q2 2023$26,681,827
+7.5%
3,180,194
+27.3%
0.00%0.0%
Q1 2023$24,816,669
+43.1%
2,499,161
+0.3%
0.00%
Q4 2022$17,346,193
+29.1%
2,492,269
-0.9%
0.00%
Q3 2022$13,434,000
+38.2%
2,515,884
+3.2%
0.00%
Q2 2022$9,723,000
-26.1%
2,436,758
-17.7%
0.00%
Q1 2022$13,165,000
+17.0%
2,961,635
+5.2%
0.00%
Q4 2021$11,256,000
-53.0%
2,813,924
+3.2%
0.00%
-100.0%
Q3 2021$23,947,000
-21.6%
2,727,396
+1.1%
0.00%0.0%
Q2 2021$30,551,000
+25.3%
2,696,450
+31.4%
0.00%0.0%
Q1 2021$24,384,000
+120.0%
2,052,495
+27.0%
0.00%
Q4 2020$11,086,000
-9.4%
1,616,005
-2.2%
0.00%
Q3 2020$12,239,000
+184.2%
1,651,758
+59.9%
0.00%
Q2 2020$4,307,000
+54.8%
1,032,971
-8.3%
0.00%
Q1 2020$2,783,000
-57.4%
1,126,642
+0.1%
0.00%
Q4 2019$6,538,000
+9.9%
1,125,332
-0.3%
0.00%
Q3 2019$5,948,000
-10.8%
1,128,617
+1.5%
0.00%
Q2 2019$6,671,000
-30.9%
1,111,944
+4.0%
0.00%
Q1 2019$9,654,000
+5.8%
1,069,075
-2.8%
0.00%
Q4 2018$9,127,000
-30.2%
1,099,620
+16.0%
0.00%
-100.0%
Q3 2018$13,081,000
+118.2%
947,876
+25.7%
0.00%
Q2 2018$5,995,000
+14.6%
754,169
+8.1%
0.00%
Q1 2018$5,232,000
+10.1%
697,634
-0.1%
0.00%
Q4 2017$4,750,000
+40.0%
698,534
+48.3%
0.00%
Q3 2017$3,392,000
+137.0%
471,031
+54.6%
0.00%
Q2 2017$1,431,000
-3.0%
304,633
+3.2%
0.00%
Q1 2017$1,476,000
+89.5%
295,226
+102.9%
0.00%
Q4 2016$779,000
-25.3%
145,472
+9.5%
0.00%
Q3 2016$1,043,000
+46.5%
132,886
+6.2%
0.00%
Q2 2016$712,000
+40.2%
125,125
+3.1%
0.00%
Q1 2016$508,000
-36.7%
121,407
+2.6%
0.00%
Q4 2015$802,000
-99.6%
118,340
-97.6%
0.00%
-100.0%
Q3 2015$186,567,000
+23162.7%
4,869,794
+4606.5%
0.01%
Q2 2015$802,000103,4700.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 124,096$583,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 875,931$4,117,0000.70%
Perceptive Advisors 2,885,458$13,417,0000.68%
683 Capital Management, LLC 525,093$2,442,0000.36%
Hikari Power Ltd 107,858$507,0000.07%
SABBY MANAGEMENT, LLC 97,704$454,0000.03%
Weiss Multi-Strategy Advisers LLC 62,000$288,0000.01%
ARDSLEY ADVISORY PARTNERS LP 29,104$136,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 475,000$2,209,0000.01%
Virtu KCG Holdings LLC 22,431$104,0000.00%
View complete list of ALDEYRA THERAPEUTICS INC shareholders